Journal article

Retinal neovascularization is prevented by blockade of the renin-angiotensin system

CJ Moravski, DJ Kelly, ME Cooper, RE Gilbert, JF Bertram, S Shahinfar, SL Skinner, JL Wilkinson-Berka

Hypertension | LIPPINCOTT WILLIAMS & WILKINS | Published : 2000

Abstract

Both angiotensin II and vascular endothelial growth factor are angiogenic agents that have recently been implicated in the pathogenesis of proliferative diabetic retinopathy. In this study, retinal neovascularization was examined in a model of retinopathy of prematurity with the use of neonatal transgenic (mRen-2)27 rats, which overexpress renin in tissues, and Sprague-Dawley rats. Blockers of the renin-angiotensin system were administered during the neovascularization period. The ACE inhibitor lisinopril and the angiotensin type 1 receptor antagonist losartan both increased retinal renin levels and prevented inner retinal blood vessel growth. Quantitative in situ hybridization revealed that..

View full abstract

University of Melbourne Researchers